AI주식인사이트AI Stock Insight
C

HLB

028300KOSDAQ의료용품 및 기타 의약 관련제품 제조업

47.5 / 100

Reference Date: 2026-06-10

Financial Score12.5 / 40
News Sentiment19.0 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, PBR raises overvaluation concerns. Plunged 18.1% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

HLB operates in four key sectors: healthcare, biotechnology, shipbuilding, and media commerce. The company produces and sells a range of products, including in-vitro diagnostic medical devices, oncology drugs like Rivoceranib and RLY-4008, specialty ships, and beauty devices. In the biotechnology sector, the company focuses on innovative drug development, while the shipbuilding division designs and manufactures specialty vessels and safety equipment.

Number of Employees

151people

Average Salary

60.6M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 19.194.0Point
PBR
13.12Industry Average 1.300.0Point

10.1x industry avg (risky)

ROE
-41.07Industry Average -4.893.5Point

8.4x industry avg (excellent)

Debt Ratio
17.82Industry Average 6.860.0Point

2.6x industry avg (risky)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲41.2% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲8.6% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -30.1% (declining, 3yr)

Detailed News Sentiment

50 totalPositive 28Neutral 4Negative 18Average Sentiment Score 76

Detailed Momentum

52-week position3.0Point

52w lower range (37%)

Current 48,700Won52-week high 68,20052-week low 37,000
1-month return0.0Point

1m -18.15% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0
  • Neutral주식등의대량보유상황보고서(약식)2026-06-09
  • Neutral기업설명회(IR)개최2026-06-04
  • Neutral기업설명회(IR)개최2026-05-29
  • Neutral주식등의대량보유상황보고서(약식)2026-05-29
  • Neutral주식매수선택권부여에관한신고2026-05-18